Home›Nonselective Beta Adrenergic Antagonists›Nonselective Beta Adrenergic Antagonists + Fluticasone Furoate Umeclidinium Bromide And Vilanterol Trif

Does Nonselective Beta Adrenergic Antagonists Interact with Fluticasone Furoate Umeclidinium Bromide And Vilanterol Trif?

Nonselective Beta Adrenergic Antagonists and Fluticasone Furoate Umeclidinium Bromide And Vilanterol Trif have a major drug interaction according to U.S. FDA drug labeling data. May block bronchodilatory effects of vilanterol and produce severe bronchospasm in COPD or asthma patients. Use with caution; cardioselective agents may be considered. The mechanism involves beta-blockade antagonizes beta-agonist pulmonary effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Nonselective Beta Adrenergic Antagonists and Fluticasone Furoate Umeclidinium Bromide And Vilanterol Trif occurs because beta-blockade antagonizes beta-agonist pulmonary effects. Clinically, this means may block bronchodilatory effects of vilanterol and produce severe bronchospasm in copd or asthma patients. use with caution; cardioselective agents may be considered. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Nonselective Beta Adrenergic Antagonists and your doctor is considering prescribing Fluticasone Furoate Umeclidinium Bromide And Vilanterol Trif (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Nonselective Beta Adrenergic Antagonists+💊 Fluticasone Furoate Umeclidinium Bromide And Vilanterol Trif(Trelegy Ellipta)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
—
Source
NLP:fluticasone furoate, umeclidinium bromide and vilanterol trifenatate

What this means in plain English

May block bronchodilatory effects of vilanterol and produce severe bronchospasm in COPD or asthma patients. Use with caution; cardioselective agents may be considered.

What the FDA label says

"Beta-blockade antagonizes beta-agonist pulmonary effects"

📖 Source: NLP:fluticasone furoate, umeclidinium bromide and vilanterol trifenatate

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Nonselective Beta Adrenergic Antagonists and Fluticasone Furoate Umeclidinium Bromide And Vilanterol Trif against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.